AU717238B2 - Calcitriol derivatives and their uses - Google Patents

Calcitriol derivatives and their uses Download PDF

Info

Publication number
AU717238B2
AU717238B2 AU72426/96A AU7242696A AU717238B2 AU 717238 B2 AU717238 B2 AU 717238B2 AU 72426/96 A AU72426/96 A AU 72426/96A AU 7242696 A AU7242696 A AU 7242696A AU 717238 B2 AU717238 B2 AU 717238B2
Authority
AU
Australia
Prior art keywords
group
hydrogen
vitamin
represent
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU72426/96A
Other languages
English (en)
Other versions
AU7242696A (en
Inventor
Zu Yun Cai
Hector F. Deluca
Mary E. Phelps
Heinrich K. Schnoes
Connie M. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/531,403 external-priority patent/US5952317A/en
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of AU7242696A publication Critical patent/AU7242696A/en
Application granted granted Critical
Publication of AU717238B2 publication Critical patent/AU717238B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU72426/96A 1995-09-21 1996-09-20 Calcitriol derivatives and their uses Ceased AU717238B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US53186795A 1995-09-21 1995-09-21
US08/531867 1995-09-21
US08/531,403 US5952317A (en) 1995-09-21 1995-09-21 Calcitriol derivatives and their uses
US08/531403 1995-09-21
PCT/US1996/015184 WO1997011053A1 (en) 1995-09-21 1996-09-20 Calcitriol derivatives and their uses

Publications (2)

Publication Number Publication Date
AU7242696A AU7242696A (en) 1997-04-09
AU717238B2 true AU717238B2 (en) 2000-03-23

Family

ID=27063537

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72426/96A Ceased AU717238B2 (en) 1995-09-21 1996-09-20 Calcitriol derivatives and their uses

Country Status (9)

Country Link
EP (1) EP1021401A1 (no)
JP (1) JP3372259B2 (no)
KR (1) KR100327922B1 (no)
AU (1) AU717238B2 (no)
CA (1) CA2229316C (no)
HU (1) HUP9802303A3 (no)
NO (1) NO981282L (no)
NZ (2) NZ501318A (no)
WO (1) WO1997011053A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011986A1 (en) * 1999-08-17 2001-02-22 Wisconsin Alumni Research Foundation Animal feed containing hydrolyzable calcitriol derivatives
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
WO2001040177A2 (en) 1999-12-02 2001-06-07 Women And Infants Hospital Esters of vitamin d3 and uses thereof
US20030195175A1 (en) * 2002-03-25 2003-10-16 Deluca Hector F. Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
CA2557809A1 (en) 2004-03-01 2005-09-09 Bioxell Spa Treatment of interstitial cystitis with vitamin d compounds
EP1812011A1 (en) 2004-11-12 2007-08-01 Bioxell S.p.a. Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
PL3095447T3 (pl) 2006-02-03 2022-02-14 Opko Renal, Llc Leczenie niedoboru lub deficytu witaminy d 25-hydroksywitaminą d2 i 25- hydroksywitaminą d3
ES2497494T3 (es) 2006-06-21 2014-09-23 Opko Renal, Llc Método de tratamiento y prevención del hiperparatiroidismo secundario
JP5444212B2 (ja) 2007-04-25 2014-03-19 シトクロマ インコーポレイテッド ビタミンｄ不足および欠乏症の治療方法
JP5647516B2 (ja) 2007-04-25 2014-12-24 シトクロマ インコーポレイテッド ビタミンｄ療法のための方法および化合物
KR101540369B1 (ko) 2007-04-25 2015-07-29 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
CA2683514C (en) 2007-04-25 2019-07-09 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
EP3112476B1 (en) 2008-04-02 2023-08-02 EirGen Pharma Ltd. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
SI2552484T1 (sl) 2010-03-29 2020-07-31 Opko Ireland Global Holdings, Ltd. Postopki in sestavki za znižanje ravni paratiroidnega hormona
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment
KR101983654B1 (ko) * 2018-07-24 2019-05-29 한국과학기술원 Cfc 증후군 환자의 발달 저해를 완화할 수 있는 치료용 조성물
CN114656413B (zh) * 2022-03-30 2024-04-09 南通华山药业有限公司 一种阿法骨化醇杂环酯类衍生物及其制备方法
CN114681467B (zh) * 2022-03-30 2024-03-12 南通华山药业有限公司 一种阿法骨化醇杂环酯类衍生物在制备抗肿瘤药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2026494A (en) * 1978-07-26 1980-02-06 Wisconsin Alumni Res Found Fluorinated compounds of the vitamin d structure
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206131A (en) * 1978-06-19 1980-06-03 The Upjohn Company Compounds and process
JPS5846508A (ja) * 1981-09-14 1983-03-18 日本石油化学株式会社 導電性材料の製法
IT1163846B (it) * 1982-07-26 1987-04-08 Wisconsin Alumni Res Found Analoghi della vitamina d
JPH0825993B2 (ja) * 1990-08-20 1996-03-13 大同ほくさん株式会社 ビタミンｄ２およびｄ３又は活性型ビタミンｄ２およびｄ３の製造方法，並びにその中間体
JPH05339230A (ja) * 1992-03-12 1993-12-21 Nisshin Flour Milling Co Ltd 活性型ビタミンｄ２及びその誘導体の製造法
JP3182215B2 (ja) * 1992-06-26 2001-07-03 日清製粉株式会社 １−アシルオキシビタミンｄ誘導体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
GB2026494A (en) * 1978-07-26 1980-02-06 Wisconsin Alumni Res Found Fluorinated compounds of the vitamin d structure

Also Published As

Publication number Publication date
NZ501318A (en) 2001-07-27
EP1021401A1 (en) 2000-07-26
NZ319819A (en) 2000-02-28
KR19990063628A (ko) 1999-07-26
JP3372259B2 (ja) 2003-01-27
AU7242696A (en) 1997-04-09
WO1997011053A1 (en) 1997-03-27
CA2229316C (en) 2005-04-12
NO981282L (no) 1998-05-22
NO981282D0 (no) 1998-03-20
MX9801943A (es) 1998-08-30
CA2229316A1 (en) 1997-03-27
KR100327922B1 (ko) 2002-05-09
HUP9802303A2 (hu) 1999-02-01
JPH11511475A (ja) 1999-10-05
HUP9802303A3 (en) 1999-05-28

Similar Documents

Publication Publication Date Title
AU717238B2 (en) Calcitriol derivatives and their uses
US5976784A (en) Calcitriol derivatives and their uses
US5952317A (en) Calcitriol derivatives and their uses
US5561123A (en) Method of treating proliferative skin disorders with 19-nor-vitamin D compounds
US5552392A (en) Method of treating hypoparathyroidism with (20S) vitamin D compounds
KR100321414B1 (ko) 비타민d아미드유도체
KR100271461B1 (ko) 비타민 d 아미드 유도체
EP0971888A1 (en) 2-alkyl-19-nor-vitamin d compounds
US20070213546A1 (en) 2-Propylidene-19-nor-vitamin D compounds
CA2562535C (en) 2-alkylidene-18,19-dinor-vitamin d compounds
US5373004A (en) 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
JP2002506429A (ja) ３−エピビタミンｄ２化合物及びその使用法
AU2005309747A1 (en) 2-methylene-18,19-dinor-1alpha-hydroxy-homopregnacalciferol and its uses
NZ571773A (en) 2-Methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin D3 and uses thereof
AU5117198A (en) Vitamin d3 derivatives
EP0793648A1 (en) 18-nor-vitamin d compounds
MXPA98001943A (en) Derivatives of calcitriol and its u
AU2007306292A1 (en) Novel method of treatment of male sub-fertility

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired